Sorensen Mel
SEC insider (Form 3/4/5 filer). CIK 0001444783. President and CEO at Galera Therapeutics, Inc. (GRTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in MALVERN, PA.
Companies Sorensen Mel has filed insider reports for
- Galera Therapeutics, Inc. (GRTX): Director, Officer, President and CEO
Sorensen Mel
CIK: 0001444783
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GRTX
Galera Therapeutics, Inc.
DirectorOfficer